Calyxia, a Paris, France-based industrial B2B Cleantech innovator, certified B Corp, specializing in advanced and biodegradable microcapsules and microparticles for use in Consumer Goods, Crop Protection and Advanced Materials, raised $35m in Series B funding round.
The round was led by Lombard Odier Investment Managers, through its Plastic Circularity Fund and Bpifrance, through its Large Venture Fund, with participation from existing investors including Astanor.
Founded in 2015 by a group of scientists from Harvard University (USA), ESPCI-Paris PSL (France) and Cambridge University(UK), Calyxia, is an Industrial B2B CleanTech Innovator, certified B Corp, and led by Jamie Walters, CEO and Co-Founder, Calyxia has developed proprietary and eco-designed manufacturing technology to produce the advanced performance and sustainable microparticle and microcapsule products. The products combine biodegradability, advanced performance and cost-effectiveness, allowing manufacturers to replace traditional microplastic microcapsules and microparticles based ingredients that are currently widely used and critical to the performance of cosmetics, laundry care and crop protection products.
The company intends to use the new capital to achieve profitability, deploy its manufacturing technology globally. More specifically, Calyxia plans to expand its commercial and industrial operations, beginning with the establishment of new headquarters and a second production site in the Paris Region by Q1 2025. This new facility will increase production capacity to 3,000 tons per year, paving the way for the company to achieve profitability and establish its position as the market leader.
Calyxia, which recently installed and qualified its first fully operational factory in 2023, has secured commercial partnerships for mass-volume industrial applications with leading companies in Agriculture, Consumer Care and Advanced Materials markets.
FinSMEs
09/09/2024